RenewCO2 Raises $5M In Seed Funding Round

Listen to this article

RenewCO2 raised $5 million in a seed funding round in August 2025, led by DNP, to scale its Electrocatalytic Carbon Utilization Technology (eCUT) for converting CO2 into carbon-negative chemicals and fuels.

RenewCO2, founded in 2018 and based in Somerset, New Jersey, is a cleantech startup spun out from Rutgers University. It specializes in converting carbon dioxide emissions into carbon-negative chemicals and fuels using its proprietary Electrocatalytic Carbon Utilization Technology (eCUT). The technology employs a low-cost, energy-efficient catalyst to transform CO2 and water into products like monoethylene glycol (MEG), a key component in polyester production, and other chemicals such as methylglyoxal and furandiol. The company aims to reduce the chemical industry’s reliance on fossil feedstocks, which contribute to approximately 15% of global industrial greenhouse gas emissions.

RenewCO2 secured $5 million in a seed funding round led by DNP, a significant milestone to advance its commercialization efforts. This round follows previous funding, including a $2 million seed round in September 2022 led by Energy Transition Ventures and over $8 million in non-dilutive grants and awards from entities like the U.S. Department of Energy (DOE) and the National Science Foundation (NSF). The total funding raised by RenewCO2 exceeds $15 million, reflecting strong investor confidence in its innovative approach to carbon utilization.

The funds from the 2025 seed round are designated for scaling operations, enhancing research and development, and accelerating the deployment of eCUT systems. RenewCO2 plans to supply its first commercial eCUT electrolysis systems by 2025, with a pilot-scale electrolyzer targeted for 2023 and a commercial-scale product capable of processing 3 tons of CO2 per day by 2025.

Investor Landscape

The investor base for RenewCO2 includes a mix of venture capital, government agencies, and innovation programs:

• DNP: Led the $5 million seed round in 2025, signaling strong support for RenewCO2’s technology and market potential.
• Energy Transition Ventures: A Houston-based venture capital fund focused on energy transition startups, led the $2 million seed round in 2022.
• U.S. Department of Energy (DOE): Provided grants, including $1.15 million in R&D funding and $500,000 for a feasibility study on converting waste CO2 from bioethanol production.
• National Science Foundation (NSF): Awarded a $225,000 grant in 2020 to support early-stage development.
• Other Investors: Greentown Labs, Carbon to Value Initiative, and Change Chemistry have also backed RenewCO2, contributing to its growth through incubators and accelerators.

Strategic Implications

The latest funding round positions RenewCO2 to capitalize on growing demand for sustainable chemical production. The eCUT technology’s ability to convert CO2 from various sources—industrial emissions or direct air capture—into cost-competitive, carbon-negative products aligns with global decarbonization goals and policies like the U.S. Inflation Reduction Act, which supports carbon capture and utilization (CCU). The technology’s modularity and scalability make it adaptable to diverse industrial settings, enhancing its market potential. Additionally, the funding supports job creation in manufacturing, engineering, and industrial operations, contributing to economic growth in the cleantech sector.

RenewCO2, established in 2018 in Somerset, New Jersey, is a cleantech startup that emerged from Rutgers University’s catalysis research. Co-founded by Dr. Karin Calvinho (CTO), Dr. Anders Laursen (CEO), and Professor Charles Dismukes, the company focuses on transforming carbon dioxide (CO2) emissions into valuable, carbon-negative chemicals and fuels. Its proprietary Electrocatalytic Carbon Utilization Technology (eCUT) uses a low-cost, energy-efficient catalyst to convert CO2 and water into products like monoethylene glycol (MEG), methylglyoxal, furandiol, and potentially formic acid, a liquid hydrogen carrier. These products serve as precursors for plastics used in electronics, appliances, bottles, textiles, and packaging, addressing the chemical industry’s significant contribution to global greenhouse gas emissions (approximately 920 million metric tons annually).

The eCUT process is notable for its single-step, low-temperature conversion, high selectivity, and avoidance of precious metals, making it a cost-effective alternative to traditional petrochemical processes. By leveraging renewable electricity and modular designs, RenewCO2’s technology is scalable and adaptable to various CO2 sources, including industrial point sources and direct air capture (DAC). The company’s mission is to enable industries to meet carbon neutrality goals while generating revenue from sustainable products, supported by tax incentives for carbon conversion.

Detailed Funding History

RenewCO2 has raised over $15 million through a combination of venture capital and non-dilutive funding since its inception. Below is a comprehensive breakdown of its funding rounds and grants:

Total Funding:

• Venture Capital: Approximately $5 million (2025 seed round) + $2 million (2022 seed round) = $7 million.
• Grants and Awards: Over $8 million, including DOE, NSF, and New Jersey state grants.
• Cumulative Total: Over $15 million.

The August 2025 seed round of $5 million, led by DNP, is the largest single funding event in RenewCO2’s history, surpassing the $2 million seed round in 2022. The funds are earmarked for expanding laboratory and pilot facilities in Somerset, New Jersey, opened in December 2023, and advancing the commercialization timeline. RenewCO2 aims to deliver a pilot-scale electrolyzer by 2023 (capable of producing 1 ton of product per year) and a commercial-scale system by 2025 (processing 3 tons of CO2 per day).

Recommended: Pacific Avenue Capital Partners Closes More Than $1.65B For Its Second Fund

Investor and Partner Ecosystem

RenewCO2’s investor base reflects a blend of venture capital, government support, and innovation ecosystems:

• DNP: A new lead investor in 2025, DNP’s involvement underscores RenewCO2’s growing appeal to private capital seeking sustainable technologies.
• Energy Transition Ventures: Based in Houston, Texas, this venture capital fund focuses on early-stage energy transition startups. Its $2 million investment in 2022 supported RenewCO2’s spin-out from Rutgers and the exclusive licensing of its catalyst technology.
• U.S. Department of Energy (DOE): A key supporter, the DOE has provided multiple grants, including $1.15 million for R&D and $500,000 for a feasibility study on converting bioethanol waste CO2 into plastics monomers, aiming to reduce biofuel carbon footprints by over 70% compared to gasoline.
• National Science Foundation (NSF): The $225,000 grant in 2020 bolstered early-stage development, validating the eCUT technology’s potential.
• Incubators and Accelerators: Greentown Labs, Carbon to Value Initiative, and Change Chemistry have provided non-dilutive support, mentorship, and exposure to industry networks. The Carbon to Value (C2V) Initiative, for example, has facilitated over 500 business relationships for its startups, with RenewCO2 benefiting from corporate engagements.
• Rutgers University: Through its Innovation Ventures (now Technology Transfer) program, Rutgers provided early funding via the TechAdvance® program and facilitated the exclusive licensing of the eCUT catalyst technology.

Technology and Market Impact

The eCUT technology is a game-changer for the chemical industry, which accounts for 15% of global industrial greenhouse gas emissions. Unlike traditional petrochemical processes that rely on energy-intensive steps like steam cracking, eCUT uses a proton exchange membrane (PEM) electrolyzer with a novel cathode design to convert CO2 and water into chemicals in a single, low-temperature step. This process offers:

• High Selectivity: Produces specific chemicals like MEG with minimal byproducts.
• Energy Efficiency: Operates at low temperatures and leverages renewable electricity.
• Carbon-Negative Output: Removes 1.42 tons of CO2 per ton of product, potentially reducing global CO2 emissions by 91.6 million metric tons annually if widely adopted for MEG production.
• Scalability: Modular design suits various CO2 sources, from industrial emissions to DAC.

The technology’s primary product, MEG, is a critical monomer for polyethylene terephthalate (PET) used in plastics. RenewCO2’s pipeline also includes methylglyoxal, furandiol, and formic acid, expanding its market reach. The company’s ability to produce cost-competitive, carbon-negative alternatives positions it to disrupt the $1 trillion chemical industry, particularly as demand for sustainable products grows.

Strategic and Economic Implications

The $5 million seed round strengthens RenewCO2’s path to commercialization, aligning with global trends toward decarbonization and sustainable manufacturing. The U.S. Inflation Reduction Act’s support for CCU technologies enhances the economic viability of eCUT systems, as companies can leverage tax incentives for carbon conversion. The technology’s agnostic approach to CO2 sources makes it versatile for industries like petrochemicals, biofuels, and power generation.

Economically, RenewCO2’s growth supports job creation in high-skill sectors like manufacturing, engineering, and R&D. The opening of its Somerset facility in December 2023, celebrated with industry and government stakeholders, underscores its role in New Jersey’s innovation ecosystem. Leadership recognition, such as Dr. Calvinho and Dr. Laursen’s inclusion in Innovate New Jersey’s INNOVATE100 in May 2024, highlights the company’s influence in cleantech.

Competitive Landscape

RenewCO2 operates in the carbon capture, utilization, and storage (CCUS) space, competing with companies like Twelve (Berkeley, CA) and Avantium. Its unique value proposition lies in its single-step, energy-efficient process and proprietary catalyst, which outperforms natural systems in selectivity and speed. The company’s focus on cost-competitive, carbon-negative products differentiates it from competitors relying on multi-step processes or less scalable technologies.

With the 2025 funding, RenewCO2 is well-positioned to achieve its commercialization timeline, delivering pilot systems by 2023 and commercial units by 2025. The company’s focus on expanding its product portfolio (e.g., formic acid) and leveraging partnerships with industry leaders like LG Chem, which selected RenewCO2 as a finalist in its Global Innovation Challenge, enhances its market prospects. Continued support from government grants and accelerators will further de-risk its technology, attracting additional private investment.

Please email us your feedback and news tips at hello(at)superbcrew.com